Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

440 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis.
Maurer MS, Kale P, Fontana M, Berk JL, Grogan M, Gustafsson F, Hung RR, Gottlieb RL, Damy T, González-Duarte A, Sarswat N, Sekijima Y, Tahara N, Taylor MS, Kubanek M, Donal E, Palecek T, Tsujita K, Tang WHW, Yu WC, Obici L, Simões M, Fernandes F, Poulsen SH, Diemberger I, Perfetto F, Solomon SD, Di Carli M, Badri P, White MT, Chen J, Yureneva E, Sweetser MT, Jay PY, Garg PP, Vest J, Gillmore JD; APOLLO-B Trial Investigators. Maurer MS, et al. Among authors: taylor ms. N Engl J Med. 2023 Oct 26;389(17):1553-1565. doi: 10.1056/NEJMoa2300757. N Engl J Med. 2023. PMID: 37888916 Free PMC article. Clinical Trial.
Alterations in multi-layer strain in AL amyloidosis.
Sivapathan S, Geenty P, Deshmukh T, Boyd A, Richards D, Stewart G, Taylor MS, Kwok F, Thomas L. Sivapathan S, et al. Among authors: taylor ms. Amyloid. 2022 Jun;29(2):128-136. doi: 10.1080/13506129.2022.2026914. Epub 2022 Feb 21. Amyloid. 2022. PMID: 35188014
Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial.
Adams D, Tournev IL, Taylor MS, Coelho T, Planté-Bordeneuve V, Berk JL, González-Duarte A, Gillmore JD, Low SC, Sekijima Y, Obici L, Chen C, Badri P, Arum SM, Vest J, Polydefkis M; HELIOS-A Collaborators. Adams D, et al. Among authors: taylor ms. Amyloid. 2023 Mar;30(1):1-9. doi: 10.1080/13506129.2022.2091985. Epub 2022 Jul 23. Amyloid. 2023. PMID: 35875890 Clinical Trial.
Current approaches to the diagnosis and management of amyloidosis.
Taylor MS, Sidiqi H, Hare J, Kwok F, Choi B, Lee D, Baumwol J, Carroll AS, Vucic S, Neely P, Korczyk D, Thomas L, Mollee P, Stewart GJ, Gibbs SDJ. Taylor MS, et al. Intern Med J. 2022 Dec;52(12):2046-2067. doi: 10.1111/imj.15974. Epub 2022 Dec 7. Intern Med J. 2022. PMID: 36478370 Review.
Cardiac "hypertrophy" phenotyping: differentiating aetiologies with increased left ventricular wall thickness on echocardiography.
Ferkh A, Tjahjadi C, Stefani L, Geenty P, Byth K, De Silva K, Boyd AC, Richards D, Mollee P, Korczyk D, Taylor MS, Kwok F, Kizana E, Ng ACT, Thomas L. Ferkh A, et al. Among authors: taylor ms. Front Cardiovasc Med. 2023 Jul 3;10:1183485. doi: 10.3389/fcvm.2023.1183485. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37465456 Free PMC article.
Left Ventricular Mass-To-Strain Ratio Predicts Cardiac Amyloid Subtype.
Geenty P, Sivapathan S, Stefani LD, Boyd A, Richards D, Kwok F, Taylor MS, Stewart G, Thomas L. Geenty P, et al. Among authors: taylor ms. JACC Cardiovasc Imaging. 2021 Mar;14(3):690-692. doi: 10.1016/j.jcmg.2020.08.035. Epub 2020 Nov 18. JACC Cardiovasc Imaging. 2021. PMID: 33221214 Free article. No abstract available.
The Authors Reply.
Thomas L, Geenty P, Ferkh A, Taylor MS, Kwok F. Thomas L, et al. Among authors: taylor ms. JACC Cardiovasc Imaging. 2021 Sep;14(9):1878-1879. doi: 10.1016/j.jcmg.2021.07.016. JACC Cardiovasc Imaging. 2021. PMID: 34503692 Free article. No abstract available.
440 results